Cargando…
YB-1 Expression Is Associated with Lymph Node Metastasis and Drug Resistance to Adriamycin in Breast Cancer
BACKGROUND: Breast cancer (BC) is the most common malignant tumor among females. Although there are multiple treatments for breast cancer, many patients still face the dilemma of drug resistance after multiline treatment. It would be greatly helpful for clinical work to identify additional and impro...
Autores principales: | Dong, Hanzhi, Jian, Yan, Yu, Tenghua, Wang, Meijian, Zhang, Wenfeng, Peng, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922184/ https://www.ncbi.nlm.nih.gov/pubmed/36785738 http://dx.doi.org/10.1155/2023/4667089 |
Ejemplares similares
-
Hepatic artery intervention combined with immune-targeted therapy is superior to sequential therapy in BCLC-C hepatocellular carcinoma
por: Dong, Hanzhi, et al.
Publicado: (2022) -
Delivery of Lymph Node‐targeted Adriamycin by Gastric Submucosal Liposomal Injection in Rabbits
por: Akamo, Yoshimi, et al.
Publicado: (1993) -
Breast Axillary Lymph Node Metastasis
por: Cavalli, Luciane R., et al.
Publicado: (2011) -
Lymphangiogenesis and lymph node metastasis in breast cancer
por: Cunnick, Giles H, et al.
Publicado: (2008) -
Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node
por: Zhou, Yidong, et al.
Publicado: (2019)